Executive record

Carolyn Tang

General Counsel at Arcus Biosciences, Inc.

Follow
More
Challenge a Claim

Alpha ID: alpha:person:carolyn-tangVersion: public-0As of: 2026-09-29

Not yet claimed6 published Claims2 sources
  • Counsel

Key Claims

Biography

Has served as General Counsel since September 2019, having joined Arcus in 2017. Previously served as Director of Securities and Transactions at Medivation and held roles at InterMune covering intellectual property, corporate and securities activities.

Alpha editorial summary written from the cited sources below. It does not change any Claim on this record.

Executive career

  1. Current · dates not publishedGeneral Counsel · Arcus Biosciences, Inc.
  2. 2026 to end not publishedExecutive title: General Counsel · Organization not publishedRCUS DEF 14A executive officers

Claims

Conflicts and accountability

Alpha has not published independence, related-party, proceedings or disciplinary Claims for this record. This is not a finding that none exist.

Only disclosed facts and public registers appear here. Executive records carry no credit, personal litigation, background screening or underwriting views. None observed is not a clearance.

Evidence, history and coverage

Additional published Claims

Published evidence records

2 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. RCUS DEF 14A executive officers

    sec filing · Source published: Apr 21, 2026 · Retrieved: May 5, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 5, 2026
    • Executive company: Executive at Arcus Biosciences, Inc. · Claim reviewed: May 5, 2026
    • Executive title: Executive title: General Counsel · Claim reviewed: May 5, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 5, 2026

  2. Open source

    sec def 14a · Source published: Apr 21, 2026 · Retrieved: Sep 12, 2026

    Supports 1 claim
    • Professional Role: General Counsel at Arcus Biosciences, Inc. · Claim reviewed: Sep 12, 2026